The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
Open accessAbstract
Patients receiving anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We reviewed the US Food and Drug Administration MedWatch database for reports of NTM disease in patients receiving anti-TNF-alpha therapy. Of 239 reports collected, 105 (44%) met NTM disease criteria. Median age was 62 years; the majority of patients (66, 65%) were female, and most (73, 70%) had rheumatoid arthritis. NTM infections were associated with infliximab (n = 73), etanercept (n = 25), and adalimumab (n = 7); most patients were taking prednisone (n = 68, 65%) or methotrexate (n = 58, 55%) concurrently. Mycobacteria avium (n = 52, 50%) was most commonly implicated, and 9 patients (9%) had died at the time their infections were reported. A high rate of extrapulmonary manifestations (n = 46, 44%) was also reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationTuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists
Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004) · Clinical Infectious Diseases · doi:10.1086/383317 · Cited by 977
THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS
Gabriel, S. E. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70201-5 · Cited by 782
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Self-citationCarmona, L., Gómez‐Reino, J. J., Rodríguez‐Valverde, V., Montero, D., Pascual‐Gómez, E., Mola, E. M., Carreño, L., Figueroa, M., & BIOBADASER Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21043 · Cited by 656
Nontuberculous mycobacteria in the environment
Falkinham, J. O. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(02)00014-x · Cited by 434
British Thoracic Society Standards of Care Committee (2005) · Thorax · doi:10.1136/thx.2005.046797 · Cited by 432
Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor
Mohan, A. K., Timothy, R. C., Block, J. A., Manadan, A. M., Siegel, J. N., & Braun, M. M. (2004) · Clinical Infectious Diseases · doi:10.1086/421494 · Cited by 303
Winthrop, K. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0336 · Cited by 280
Self-citationDefects in the interferon‐γ and interleukin‐12 pathways
Rosenzweig, S. D., & Holland, S. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00227.x · Cited by 219
Granulomatous Infections Due to Tumor Necrosis Factor Blockade: Correction
Wallis, R. S., Broder, M., Wong, J., & Beenhouwer, D. (2004) · Clinical Infectious Diseases · doi:10.1086/424455 · Cited by 219
Winthrop, K. L., Yamashita, S., Beekmann, S. E., Polgreen, P. M., & Infectious Diseases Society of America Emerging Infections Network (2008) · Clinical Infectious Diseases · doi:10.1086/587989 · Cited by 196
Self-citationUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Sieper, J., Emery, P., Keystone, E., Schiff, M., Mease, P. J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081430 · Cited by 153
Hyrich, K. L., Symmons, D. P. M., Watson, K. D., & Silman, A. J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.043158 · Cited by 94
Allaire, S. H., Wolfe, F., Niu, J., Zhang, Y., Zhang, B., & LaValley, M. P. (2008) · Arthritis Care & Research · doi:10.1002/art.23923 · Cited by 59
Mycobacterial disease in patients with rheumatic disease
van Ingen, J., Boeree, M. J., Dekhuijzen, P. R., & van Soolingen, D. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0949 · Cited by 47
van Ingen, J., Boeree, M. J., Janssen, M., Ullmann, E. F., de Lange, W., de Haas, P., Dekhuijzen, R. P. N., & van Soolingen, D. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0538 · Cited by 44
Winthrop, K. L., Daley, C. L., & Griffith, D. E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0621 · Cited by 6
Self-citation
Cited by
Haworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210927 · Cited by 785
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
Adjemian, J., Olivier, K. N., Seitz, A. E., Holland, S. M., & Prevots, D. R. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2016oc · Cited by 690
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Self-citationBrown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
The Rise of Non-Tuberculosis Mycobacterial Lung Disease
Ratnatunga, C. N., Lutzky, V. P., Kupz, A., Doolan, D. L., Reid, D. W., Field, M., Bell, S. C., Thomson, R. M., & Miles, J. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00303 · Cited by 483
Metadata
- Authors
- Winthrop, K. L., Chang, E., Yamashita, S., Iademarco, M. F., & LoBue, P. A.
- Venue
- Emerging Infectious Diseases
- Published
- 2009-10
- Volume
- 15
- Issue
- 10
- Pages
- 1556-1561
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2128881423
- Cited by
- 320
- References
- 21
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.